✦ LIBER ✦

Prospective randomized comparison of conventional instruments and the Harmonic Focus® device in breast-conserving therapy for primary breast cancer

✍ Scribed by D. Böhm; A. Kubitza; A. Lebrecht; M. Schmidt; A. Gerhold-Ay; M. Battista; K. Stewen; C. Solbach; H. Kölbl

Book ID: 116444529
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 38
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2011.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patients’ subjective evaluation of early

Patients’ subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy: comparison with conventional fractionation

✍ Taisuke Inomata; Isamu Narabayashi; Yuki Inada; Taiju Shimbo; Masatsugu Takahash 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 168 KB

Prospective randomized phase II study de

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer

✍ Yoshinori Ito; Koichi Nagasaki; Yoshio Miki; Takuji Iwase; Futoshi Akiyama; Masa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

P178 Prospective comparison of uPA/PAI-1

P178 Prospective comparison of uPA/PAI-1, Ki-67 based molecular classification, Recurrence Score and clinical–pathological characteristics in hormone-receptor (HR) positive primary breast cancer: Pilot phase of the randomized WSG PlanB trial

✍ C. Liedtke; O. Gluz; H. Kreipe; T. Degenhardt; R. Kates; R. Baehner; M. Clemens; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB